Search Results 101-110 of 16561 for Ovidrel

  1. Corticosteroid sprays, also called glucocorticoid sprays, prevent and relieve nasal allergy symptoms. These medicines are very effective on their own for ...

  2. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  3. Atidarsagene autotemcel (intravenous route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  4. Etripamil (nasal route) - Side effects & dosage - Mayo Clinic

    Etripamil nasal spray is used to help restore normal heart rhythm in patients who have sudden episodes of fast heartbeat called paroxysmal supraventricular ...

  5. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving ...

  6. Denosumab-desu (subcutaneous route) - Side effects & uses - Mayo Clinic

    Denosumab-desu injection is used to treat osteoporosis (thinning of the bones) in females who have an increased risk for fractures after menopause, and ...

  7. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    The postnatal diagnosis of Long QT Syndrome (LQTS) is suggested by a prolonged QT interval on 12 lead electrocardiogram (ECG),a positive family history ...

  8. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  9. Clinical trials - Gastroenterology and Hepatology

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  10. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...